Public Shareholders (WSE)
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$1.7B
Focus Areas
4
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Celon Pharma | $1.1B |
| Selvita | $664.5M |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Celon Pharma | $1.1B |
| Selvita | $664.5M |